Swiss warn on flu vaccine with autoimmune disease
ZURICH |
ZURICH (Reuters) - Switzerland's medical regulator recommended patients with serious autoimmune diseases should not use an H1N1 flu vaccine from Novartis, saying there were no studies assessing the innoculation in that population.
Swissmedic said on Wednesday it could not be ruled out that either or both of the adjuvant -- which can enhance the immune response -- and the antigen, or less active ingredient, could lead to an intensifying of autoimmune diseases.
Autoimmune diseases, like rheumatoid arthritis, are caused by an overly active immune system attacking its own body, targeting substances which are normally present.
Novartis was not immediately available to comment.
(Reporting by Sam Cage)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (2)
Sandylu wrote:
We wonder if the H1N1 vaccine Pandemrix is in the same category?
LovingTruth wrote:
Each and every vaccine is dangerous, with and without mercury, squalene, formaldehyde, anti-freeze etc.
Many doctors from the late 1800s and early 1900s have testified that vaccination is nothing but blood poisoning. Additionally they stated that vaccination causes cancer.
With healthy food, vital and pure water and a healthy lifestyle there is no need for any vaccine, pill, or doctor!
Many doctors from the late 1800s and early 1900s have testified that vaccination is nothing but blood poisoning. Additionally they stated that vaccination causes cancer.
With healthy food, vital and pure water and a healthy lifestyle there is no need for any vaccine, pill, or doctor!
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters